Share with your friends

Legislative update: Ways and Means drug pricing bill, with tax provision

Ways and Means drug pricing bill, with tax provision

The House Ways and Means Committee on October 22, 2019, approved (by a vote of 24-17) H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.


Related content

The bill includes an excise tax on selected drugs during periods in which the manufacturer is not in compliance with certain requirements of a proposed new drug price negotiation program.


  • Read a description of the bill prepared by the Joint Committee on Taxation: JCX-43-19

  • Read the Ways and Means Chairman’s statement and a statement from the ranking member in opposition to the bill

The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us


Want to do business with KPMG?


loading image Request for proposal